NASDAQ:FOLD

Stocks Trading

Do investors need to be concerned about Amicus Therapeutics Inc (FOLD)?

Cameron Mitchell

Within its last year performance, FOLD fell by -13.38%, with highs and lows ranging from $12.65 to $5.51, whereas the ...

Financial Scores

Amicus Therapeutics Inc (FOLD)’s stock performance: a year in review

Kenneth Phillips

While Amicus Therapeutics Inc has overperformed by 7.00%, investors are advised to look at stock chart patterns for technical insight. ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.